Related Experiment Video
Updated: Jun 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Nutritional management of hyperkalemic infants with chronic kidney disease, using adult renal formulas
David J Hobbs1, Tracy R Gast, Karen B Ferguson
1Department of Pediatric Nephrology, Dialysis, and Transplantation, Helen DeVos Children's Hospital and Michigan State University College of Human Medicine, Grand Rapids, Michigan 49503, USA.
Insights
Adult renal formulas effectively managed hyperkalemic infants with chronic kidney disease (CKD), reducing potassium intake and improving growth metrics. These formulas were well-tolerated and demonstrated significant benefits in pediatric patients.
Area of Science:
- Pediatric Nephrology
- Nutritional Science
- Chronic Kidney Disease Management
Background:
- Hyperkalemia is a significant concern in infants with chronic kidney disease (CKD).
- Standard infant formulas may not adequately address the complex nutritional needs of these patients, potentially leading to inadequate growth and electrolyte imbalances.
- Adult renal formulas offer specialized nutritional profiles that may be beneficial.
Purpose of the Study:
- To evaluate the efficacy and safety of using adult renal formulas for nutritional management in hyperkalemic infants diagnosed with chronic kidney disease (CKD).
Main Methods:
- A retrospective, single-center cohort study involving seven hyperkalemic infants with varying stages of CKD (3-5).
- Infants were transitioned from standard infant formulas to adult renal formulas due to inadequate growth and hyperkalemia.
- Outcome measures included potassium intake, serum potassium levels, and anthropometric z-scores.
Main Results:
- Transition to adult renal formulas significantly decreased potassium delivery (2.6 to 1.0 mEq/kg/day) and lowered mean serum potassium levels (5.1 to 4.0 mmol/L).
- Infants showed significant improvements in weight, height, and head-circumference z-scores during treatment with adult renal formulas.
- Adult renal formulas were well-tolerated by the study population.
Conclusions:
- Adult renal formulas provide a viable and effective nutritional management strategy for hyperkalemic infants with chronic kidney disease (CKD).
- This approach can help normalize potassium levels and support improved growth in this vulnerable pediatric population.
Objective:
This study sought to evaluate the use of adult renal formulas in hyperkalemic infants with chronic kidney disease (CKD).
Design:
This was a retrospective, single-center cohort study.
Setting:
This study took place at the Department of Pediatric Nephrology, Dialysis, and Transplantation at Helen DeVos Children's Hospital (Grand Rapids, MI).
Patients:
Seven hyperkalemic infants (mean age, 6.9 months) comprised the study population: 29% with stage 3 CKD, 29% with stage 4 CKD, and 42% with stage 5 CKD.
Intervention:
Infants were empirically treated with adult renal formulas for an average duration of 9.6 months. Six of seven infants were started on breast milk or infant formula (Similac PM 60/40, Abbott Laboratories, Columbus, OH), but because of inadequate growth and hyperkalemia, were transitioned to adult renal formulas (Suplena, Abbott Laboratories, Columbus, OH; Nepro, Abbott Laboratories, Columbus, OH; and/or Renalcal, Nestle Nutrition, Minnetonka, MN). One infant received adult renal formula at birth.
Main Outcome Measures:
The outcome measures included amount of potassium delivered by infant and adult renal formulas, level of serum potassium, and anthropometric measurements adjusted for age and gender (z-scores).
Results:
The transition from infant to adult renal formula resulted in a decrease in mean amount of potassium delivered by formula (from 2.6 to 1.0 mEq/kg/day, P < .001) and a decrease in mean serum potassium (from 5.1 to 4.0 mmol/L, P < .01). During treatment with adult renal formula, the infants demonstrated a significant increase in mean weight z-score (from -1.0 to 0.5, P < .01), height z-score (from -1.9 to -0.5, P < .01), and head-circumference z-score (from -1.5 to -1.0, P=.03). Adult renal formulas were well-tolerated.
Conclusions:
Hyperkalemic infants with CKD can be nutritionally managed on adult renal formula.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury VI: Nursing Management
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Pharmacokinetics in Pediatric Patients: Drug Excretion
